ConductScience.org, home

Comparison · NCT00367341-e22a79ef

Escitalopram vs Cognitive Behavioral Therapy: Response Defined as 50% Change in Hamilton Depression Rating Scale-17 Score at 12 Weeks

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Escitalopram vs Cognitive Behavioral Therapy: Response Defined as 50% Change in Hamilton Depression Rating Scale-17 Score at 12 Weeks. Trial comparisons, record NCT00367341-e22a79ef. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00367341-e22a79ef

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.5630.3930.718wilson
Risk in group 20.5810.4080.736wilson
Risk difference, group 1 minus group 2-0.0181-0.2480.215newcombe hybrid score
Risk ratio, group 1 over group 20.9690.6321.49log
Odds ratio, group 1 over group 20.9290.3422.52log
Number needed to treat, for one fewer participant with the outcome on Escitalopram than on Cognitive Behavioral Therapy55.1from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Escitalopramescitalopram : Participants will receive treatment with escitalopram for 12 weeks.1832OG000
Group 2Cognitive Behavioral TherapyCognitive Behavioral Therapy (CBT) : CBT will include 16 1 hour sessions provided over 12 weeks.1831OG001

Outcome

Type
SECONDARY
Title
Response Defined as 50% Change in Hamilton Depression Rating Scale-17 Score at 12 Weeks
Description
Number of participants with a 50% change from Baseline on the Hamilton Depression Rating Scale-17-item score
Time frame
Measured at week 12.
Population
completers

Source ClinicalTrials.gov

Trial

Title
Imaging Predictors of Treatment Response in Depression
NCT number
NCT00367341
Phases
NA
Conditions
Major Depressive Disorder
Interventions
escitalopram, Cognitive Behavioral Therapy (CBT)
Lead sponsor
Emory University
Results first posted
2014-01-09

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00367341-e22a79ef